On November 7th, UFC veteran Gleison Tibau will finally have the opportunity to get his career back on track. It will be the day when his two-year suspension for testing positive for a banned substance will lapse.
Tibau was found to have erythropoietin (EPO) in his system during both in and out of competition drug tests for his fight against Abel Trujillo in Sao Paulo in November 2015. His submission win was overturned to a disqualification loss.
As stated on the World Anti-Doping Agency (WADA) website, EPO aims to stimulate red blood cell production, which ultimately improves the amount of oxygen that the blood can carry to the body’s muscle.